Mark Reddish
Chief Operating Officer at Metrodora Therapeutics, Inc.
Profile
Mark Reddish is currently working as Vice President-Operation at Metrodora Therapeutics, Inc. He previously worked as Senior Director-Research Immunology at Biomira, Inc. from 1991 to 1998, Vice President-Product Development at ID Biomedical Corp.
from 1998 to 2005, and as an Independent Director at Marker Therapeutics, Inc. from 2014 to 2018.
He completed his undergraduate degree from the University of Massachusetts.
Mark Reddish active positions
| Companies | Position | Start |
|---|---|---|
| Metrodora Therapeutics, Inc. | Chief Operating Officer | - |
Former positions of Mark Reddish
| Companies | Position | End |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Director/Board Member | 17/10/2018 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2005 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Corporate Officer/Principal | 01/01/1998 |
Training of Mark Reddish
| University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Metrodora Therapeutics, Inc. | |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
- Stock Market
- Insiders
- Mark Reddish
